Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$118,566,148
+$4,123,985 QoQ
Shares Held
466,851
-0.3% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#272
of 4,664 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $673,665,379 across 15 Drug Manufacturers - General names. JNJ ranks #2 (17.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
222,559 | $266,943,963 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
466,851 | $118,566,148 | |
| 3 | ABBV |
AbbVie Inc.
|
350,912 | $88,303,495 | |
| 4 | MRK |
Merck & Co., Inc.
|
473,483 | $60,842,565 | |
| 5 | AMGN |
Amgen Inc
|
133,818 | $48,458,174 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
238,168 | $30,090,145 | |
| 7 | PFE |
Pfizer Inc
|
1,108,420 | $26,690,753 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
444,025 | $25,584,720 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $118,566,148 | 466,851 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $114,442,163 | 468,181 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $84,905,790 | 410,272 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $72,451,937 | 390,745 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $62,152,294 | 406,889 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $64,605,127 | 389,563 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $56,293,479 | 389,251 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $59,423,026 | 366,673 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $52,907,289 | 361,982 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $58,381,443 | 369,059 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $53,984,390 | 344,420 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $48,936,650 | 314,200 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $54,318,036 | 328,166 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $51,569,585 | 332,707 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $57,100,699 | 323,242 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $45,360,988 | 277,675 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $41,696,743 | 234,898 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $42,438,077 | 239,452 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $40,441,803 | 236,405 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $32,465,376 | 201,024 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $35,276,929 | 214,137 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $39,563,153 | 240,725 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $38,044,254 | 241,735 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $35,436,268 | 238,019 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $36,440,326 | 259,122 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||